Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Guardant Health PE Ratio 2017-2019 | GH

Current and historical p/e ratio for Guardant Health (GH) from 2017 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Guardant Health PE ratio as of April 01, 2020 is 0.00.
  
Guardant Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-04-02 65.12 0.00
2019-12-31 78.14 $-0.84 0.00
2019-09-30 63.83 $-0.87 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.295B $0.214B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.670B 13.34
Gilead Sciences (GILD) United States $91.291B 11.81
CSL (CSLLY) Australia $82.501B 0.00
Vertex Pharmaceuticals (VRTX) United States $58.460B 53.05
Regeneron Pharmaceuticals (REGN) United States $54.640B 23.14
Biogen (BIIB) United States $51.048B 8.72
Illumina (ILMN) United States $37.700B 38.98
Alexion Pharmaceuticals (ALXN) United States $19.973B 9.26
Seattle Genetics (SGEN) United States $19.162B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $16.080B 34.50
BioMarin Pharmaceutical (BMRN) United States $15.040B 643.00
Genmab (GMAB) Denmark $12.907B 10.13
Galapagos (GLPG) Belgium $11.998B 26.20
BioNTech SE (BNTX) Germany $11.974B 0.00
Genmab (GNMSF) Denmark $11.937B 38.39
Alnylam Pharmaceuticals (ALNY) United States $11.821B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.513B 49.14
Moderna (MRNA) United States $9.762B 0.00
QIAGEN (QGEN) Netherlands $9.160B 27.93
Exact Sciences (EXAS) United States $8.268B 0.00
BeiGene (BGNE) Cayman Islands $8.070B 0.00
Sarepta Therapeutics (SRPT) United States $7.233B 0.00
Bio-Techne Corp (TECH) United States $7.112B 48.67
ACADIA Pharmaceuticals (ACAD) United States $6.099B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.742B 15.17
Ascendis Pharma (ASND) Denmark $5.395B 0.00
Exelixis (EXEL) United States $5.027B 16.14
Repligen (RGEN) United States $4.913B 89.84
ARGENX SE-ADR (ARGX) Netherlands $4.857B 0.00
Acceleron Pharma (XLRN) United States $4.481B 0.00
Reata Pharmaceuticals (RETA) United States $4.412B 0.00
China Biologic Products (CBPO) China $4.215B 25.02
Adaptive Biotechnologies (ADPT) United States $3.475B 0.00
Vir Biotechnology (VIR) United States $3.269B 0.00
MorphoSys AG (MOR) Germany $3.218B 0.00
Mirati Therapeutics (MRTX) United States $3.131B 0.00
Blueprint Medicines (BPMC) United States $3.084B 0.00
Global Blood Therapeutics (GBT) United States $2.964B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.891B 0.00
Zai Lab (ZLAB) China $2.837B 0.00
Emergent Biosolutions (EBS) United States $2.825B 19.61
NeoGenomics (NEO) United States $2.755B 119.46
Ultragenyx Pharmaceutical (RARE) United States $2.716B 0.00
Bluebird Bio (BLUE) United States $2.364B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.343B 39.69
Amicus Therapeutics (FOLD) United States $2.279B 0.00
RA PHARMCTL INC (RARX) United States $2.272B 0.00
Halozyme Therapeutics (HALO) United States $2.253B 0.00
Alkermes (ALKS) Ireland $2.193B 173.75
Immunomedics (IMMU) United States $2.169B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.078B 0.00
MyoKardia (MYOK) United States $2.059B 0.00
Arena Pharmaceuticals (ARNA) United States $2.048B 5.33
UniQure (QURE) Netherlands $2.019B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.919B 0.00
Viela Bio (VIE) United States $1.862B 0.00
Amarin (AMRN) Ireland $1.779B 0.00
Principia Biopharma (PRNB) United States $1.747B 0.00
Eidos Therapeutics (EIDX) United States $1.742B 0.00
Alector (ALEC) United States $1.717B 0.00
Denali Therapeutics (DNLI) United States $1.688B 0.00
Zymeworks (ZYME) Canada $1.538B 0.00
Fate Therapeutics (FATE) United States $1.535B 0.00
Arvinas (ARVN) United States $1.504B 0.00
Epizyme (EPZM) United States $1.379B 0.00
Akcea Therapeutics (AKCA) United States $1.377B 29.61
Dicerna Pharmaceuticals (DRNA) United States $1.278B 0.00
Insmed (INSM) United States $1.267B 0.00
Zealand Pharma (ZEAL) Denmark $1.130B 0.00
Ligand Pharmaceuticals (LGND) United States $1.127B 35.01
Inovio Pharmaceuticals (INO) United States $1.123B 0.00
REGENXBIO (RGNX) United States $1.082B 0.00
Coherus BioSciences (CHRS) United States $1.071B 12.74
Editas Medicine (EDIT) United States $1.015B 0.00
PHARMA MAR SA (PHMMF) Spain $0.996B 0.00
Twist Bioscience (TWST) United States $0.996B 0.00
Myriad Genetics (MYGN) United States $0.977B 17.24
NextCure (NXTC) United States $0.963B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.811B 0.00
Intra-Cellular Therapies (ITCI) United States $0.801B 0.00
Beam Therapeutics (BEAM) United States $0.801B 0.00
I-Mab (IMAB) China $0.770B 0.00
Novavax (NVAX) United States $0.723B 0.00
Sangamo Therapeutics (SGMO) United States $0.722B 0.00
Revance Therapeutics (RVNC) United States $0.719B 0.00
Adverum Biotechnologies (ADVM) United States $0.696B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.678B 0.00
Cytokineticsorporated (CYTK) United States $0.663B 0.00
Athersys (ATHX) United States $0.653B 0.00
Kadmon Holdings (KDMN) United States $0.650B 0.00
Arcus Biosciences (RCUS) United States $0.642B 0.00
Athenex (ATNX) United States $0.633B 0.00
Pharming Group (PHGUF) Netherlands $0.632B 0.00
Bellus Health (BLU) Canada $0.627B 0.00
Codexis (CDXS) United States $0.621B 0.00
Retrophin (RTRX) United States $0.605B 0.00
Cara Therapeutics (CARA) United States $0.579B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.575B 0.00
GENFIT S.A (GNFT) France $0.549B 0.00
Intellia Therapeutics (NTLA) United States $0.545B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.518B 4.56
Castle Biosciences (CSTL) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.489B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
AC Immune SA (ACIU) Switzerland $0.483B 12.33
Compugen (CGEN) Israel $0.477B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.469B 0.00
Intrexon (PGEN) United States $0.467B 0.00
Frequency Therapeutics (FREQ) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.458B 0.00
ANI Pharmaceuticals (ANIP) United States $0.457B 8.25
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Prothena (PRTA) Ireland $0.439B 0.00
Clovis Oncology (CLVS) United States $0.418B 0.00
Morphic Holding (MORF) United States $0.415B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.414B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
Heska (HSKA) United States $0.409B 0.00
Anika Therapeutics (ANIK) United States $0.403B 13.89
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Verastem (VSTM) United States $0.393B 0.00
Vericel (VCEL) United States $0.382B 56.73
Agenus (AGEN) United States $0.373B 0.00
Cel-Sci (CVM) United States $0.371B 0.00
Cellectis S.A (CLLS) France $0.365B 0.00
AnaptysBio (ANAB) United States $0.363B 0.00
BioDelivery Sciences (BDSI) United States $0.359B 41.44
MiMedx (MDXG) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.357B 0.00
Cue Biopharma (CUE) United States $0.345B 0.00
UROGEN PHARMA (URGN) United States $0.345B 0.00
CytomX Therapeutics (CTMX) United States $0.337B 0.00
Merus (MRUS) Netherlands $0.336B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.336B 0.00
PDL BioPharma (PDLI) United States $0.325B 9.74
Kala Pharmaceuticals (KALA) United States $0.321B 0.00
Sorrento Therapeutics (SRNE) United States $0.314B 0.00
WAVE Life Sciences (WVE) Singapore $0.311B 0.00
Scholar Rock Holding (SRRK) United States $0.309B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.287B 0.00
Dynavax Technologies (DVAX) United States $0.283B 0.00
Cellular Biomedicine (CBMG) United States $0.277B 0.00
Pfenex (PFNX) United States $0.276B 403.00
Precision BioSciences (DTIL) United States $0.271B 0.00
NantKwest (NK) United States $0.268B 0.00
Avid Bioservices (CDMO) United States $0.259B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Kamada (KMDA) Israel $0.239B 9.94
Mersana Therapeutics (MRSN) United States $0.239B 0.00
Seres Therapeutics (MCRB) United States $0.234B 0.00
Syros Pharmaceuticals (SYRS) United States $0.226B 0.00
Stemline Therapeutics (STML) United States $0.223B 0.00
Albireo Pharma (ALBO) United States $0.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Sutro Biopharma (STRO) United States $0.215B 0.00
Geron (GERN) United States $0.214B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.212B 0.00
Gritstone Oncology (GRTS) United States $0.210B 0.00
MannKind (MNKD) United States $0.203B 0.00
Aduro Biotech (ADRO) United States $0.195B 0.00
Alcobra (ARCT) United States $0.192B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.190B 1.71
Starpharma Holdings (SPHRY) Australia $0.183B 0.00
XOMA (XOMA) United States $0.181B 0.00
ChromaDex (CDXC) United States $0.179B 0.00
Selecta Biosciences (SELB) United States $0.174B 0.00
Protagonist Therapeutics (PTGX) United States $0.170B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
HOOKIPA Pharma (HOOK) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
IVERIC Bio (ISEE) United States $0.157B 0.00
VBI Vaccines (VBIV) United States $0.155B 0.00
Spero Therapeutics (SPRO) United States $0.151B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Prometic Life Sciences (LMNL) Canada $0.148B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.147B 0.00
OSMOTICA PHARM (OSMT) United States $0.146B 0.00
Fortress Biotech (FBIO) United States $0.145B 0.00
Aytu Bioscience (AYTU) United States $0.139B 0.00
AIT Therapeutics (XAIR) United States $0.138B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Kindred Biosciences (KIN) United States $0.138B 0.00
Dyadic (DYAI) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Cerecor (CERC) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
VolitionRX (VNRX) United States $0.128B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.127B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.125B 0.00
Exicure (XCUR) United States $0.123B 0.00
Theratechnologies (THTX) Canada $0.122B 0.00
Affimed (AFMD) Germany $0.121B 0.00
VTv Therapeutics (VTVT) United States $0.116B 0.00
Antibe Therapeutics (ATBPF) Canada $0.115B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.110B 0.00
IBio (IBIO) United States $0.110B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.108B 4.24
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Northwest Biotherapeutics (NWBO) United States $0.098B 0.00
Strongbridge Biopharma (SBBP) United States $0.096B 0.00
Aptinyx (APTX) United States $0.095B 0.00
Palatin Technologies (PTN) United States $0.093B 2.54
OvaScience (MLND) United States $0.091B 0.00
TELA Bio (TELA) United States $0.091B 0.00
PHASEBIO PHARMA (PHAS) United States $0.085B 0.00
CorMedix Inc (CRMD) United States $0.083B 0.00
Happiness Biotech Group (HAPP) China $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Arbutus Biopharma (ABUS) Canada $0.073B 0.00
Five Prime Therapeutics (FPRX) United States $0.073B 0.00
Eton Pharmaceuticals (ETON) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Cyclerion Therapeutics (CYCN) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.066B 3.87
Adocia (ADOCY) France $0.066B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.063B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.061B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.061B 0.00
Menlo Therapeutics (MNLO) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Synlogic (SYBX) United States $0.053B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
Catalyst Biosciences (CBIO) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Idera Pharmaceuticals (IDRA) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.033B 0.00
CollPlant Holdings (CLGN) Israel $0.033B 0.00
Lumos Pharma (LUMO) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.032B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Alimera Sciences (ALIM) United States $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
VIVUS (VVUS) United States $0.016B 0.00
Bionano Genomics (BNGO) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Unum Therapeutics (UMRX) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
ATyr Pharma (LIFE) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.010B 0.00
TrovaGene (TROV) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00